For the Quarter Ending March 2026
Bupropion Prices in North America
- In United States, the Bupropion Price Index rose quarter-over-quarter in Q1 2026, driven by elevated intermediate chemical costs.
- The Bupropion Production Cost Trend increased in March 2026 as the Producer Price Index rose 4.0 percent.
- Consumer inflation rose 3.3 percent year-over-year in March 2026, increasing transportation expenses for the Bupropion Price Index.
- The Bupropion Demand Outlook remained robust in March 2026, supported by retail sales growing 4.0 percent year-over-year.
- A stable 4.3 percent unemployment rate in March 2026 ensured health insurance access, supporting steady Bupropion consumption.
- Industrial production grew 0.7 percent year-over-year in March 2026, ensuring adequate domestic manufacturing capabilities for Bupropion synthesis.
- The Manufacturing Index expanded in March 2026, indicating stable supply chains for chemical reagents needed for Bupropion.
- Producer prices for primary basic organic chemicals used in Bupropion synthesis increased significantly in March 2026.
- Final demand for pharmaceutical preparations stabilized in March 2026, reinforcing a consistent Bupropion Price Forecast trend.
Why did the price of Bupropion change in March 2026 in North America?
- Processed energy goods costs for intermediate chemical demand jumped sharply across the region in March 2026.
- Natural gas spot prices spiked briefly in late January 2026 due to extreme winter weather.
- Producer prices for primary basic organic chemicals increased steadily during the quarter ending March 2026.
Bupropion Prices in APAC
- In China, the Bupropion Price Index rose quarter-over-quarter in Q1 2026, driven by surging bromine feedstock costs.
- The Bupropion Production Cost Trend increased during Q1 2026 as factory-gate prices rose 0.5% in March 2026.
- The Bupropion Demand Outlook strengthened in Q1 2026, supported by a 1.0% consumer inflation rate in March 2026.
- The Bupropion Price Forecast remained elevated in Q1 2026 as the Manufacturing Index expanded in March 2026.
- Industrial production grew 5.7% in March 2026, providing strong base chemical output for Bupropion in Q1 2026.
- Retail sales grew 1.7% in March 2026, showing softer spending on elective Bupropion prescriptions in Q1 2026.
- Unemployment reached 5.4% in March 2026, driving clinical need for Bupropion antidepressants during Q1 2026.
- Consumer confidence hit 91.6 in February 2026, reducing spending on Bupropion smoking cessation programs in Q1 2026.
- Bupropion API exports accelerated in Q1 2026 due to increased international procurement of Chinese intermediates in Q1 2026.
Why did the price of Bupropion change in March 2026 in APAC?
- Bromine feedstock costs for Bupropion synthesis surged significantly amid contracted domestic supply in Q1 2026.
- Domestic pharmaceutical requirements for Bupropion APIs surged following record outbound licensing deals in Q1 2026.
- Elevated sulfur raw material costs further pressured Bupropion production expenses throughout the Q1 2026 period.
Bupropion Prices in Europe
- In Germany, the Bupropion Price Index rose quarter-over-quarter in Q1 2026, driven by surging propylene feedstock costs.
- The Bupropion Production Cost Trend increased in March 2026 as 2.7% consumer inflation elevated operational expenses.
- Despite producer prices declining 0.2% in March 2026, the Bupropion Demand Outlook remained robust for exports.
- The Bupropion Price Forecast reflected upward revisions in March 2026 after the Manufacturing Index expanded, tightening supply.
- Industrial production stagnated at 0.0% in February 2026, while domestic pharmaceutical manufacturing output contracted simultaneously.
- Retail sales grew 0.7% and unemployment held at 4.2% in February 2026, supporting steady prescription purchases.
- Consumer confidence dropped to -24.7 in March 2026, negatively impacting discretionary smoking cessation purchases across Germany.
- European propylene availability tightened severely in Q1 2026, and industrial natural gas consumption spiked in January 2026.
- Pharmaceutical export volumes expanded robustly in January 2026, prompting producers to build inventories throughout Q1 2026.
Why did the price of Bupropion change in March 2026 in Europe?
- Propylene feedstock costs surged to multi-year highs in Q1 2026 amid severe geopolitical supply shocks.
- Middle Eastern supply chain disruptions severely constrained upstream petrochemical availability in Europe during March 2026.
- European natural gas benchmark prices faced upward pressure in Q1 2026 amid tight market balances.
For the Quarter Ending December 2025
Bupropion Prices in North America
- In United States, the Bupropion Price Index inched up quarter-over-quarter in Q4 2025, influenced by rising consumer prices.
- Bupropion production costs faced upward pressure as PPI increased 3.0% year-over-year in November 2025.
- Bupropion demand outlook remained strong, supported by a 3.3% year-over-year increase in retail sales in November 2025.
- Organic chemical intermediate costs and US Henry Hub natural gas spot prices faced downward pressure in Q4 2025.
- The unemployment rate of 4.4% in December 2025 indicated a strong labor market, supporting healthcare access.
- Industrial production increased 2.0% year-over-year in December 2025, despite manufacturing output declining in Q4 2025.
- US pharmaceutical preparations imports decreased in October 2025, impacting overall Bupropion supply dynamics.
- Tighter capital and higher financing costs impacted the chemical industry in Q4 2025, affecting Bupropion.
Why did the price of Bupropion change in December 2025 in North America?
- Producer Price Index increased 3.0% year-over-year in November 2025, raising Bupropion manufacturing input costs.
- Retail sales increased 3.3% year-over-year in November 2025, indicating robust consumer spending supporting healthcare.
- Organic chemical intermediate costs faced downward pressure through the end of 2025, influencing Bupropion production.
Bupropion Prices in APAC
- In China, the Bupropion Price Index rose quarter-over-quarter in Q4 2025, influenced by an upward trend in manufacturing input costs.
- Bupropion production costs trended upward in Q4 2025, despite producer prices declining 1.9% year-over-year in December 2025.
- Weak consumer spending, with retail sales growing 0.9% and CPI at 0.8% in December 2025, affected Bupropion demand.
- A 5.1% unemployment rate in December 2025 indicated reduced disposable income, indirectly affecting Bupropion demand.
- China's pharmaceutical sector thrived in 2025, bolstering Bupropion demand despite moderated overall economic growth in Q4 2025.
- Manufacturing sector expanded in December 2025, industrial production grew 5.2% year-over-year, supporting supply chains.
- China's medicine exports, including chemical active pharmaceutical ingredients, steadily increased in the first 11 months of 2025.
- Raw materials inventory declined in November 2025, but companies reported sufficient inventories in December 2025.
Why did the price of Bupropion change in December 2025 in APAC?
- Manufacturing input costs accelerated in December 2025, pressuring Bupropion production expenses upward.
- Weak consumer spending, with retail sales growing 0.9% year-over-year in December 2025, tempered Bupropion demand.
- Producer prices declined 1.9% year-over-year in December 2025, indicating lower overall input costs.
Bupropion Prices in Europe
- In Germany, the Bupropion Price Index fell quarter-over-quarter in Q4 2025, influenced by reduced producer costs in December 2025.
- Bupropion production costs decreased in Q4 2025, as the Producer Price Index declined by 2.5% year-over-year in December 2025.
- Bupropion demand remained stable in Q4 2025, supported by consistent German pharmaceutical demand for high-value therapies.
- Bromine feedstock costs for Bupropion production in Europe inched down in November 2025.
- European industrial natural gas prices remained elevated in Q4 2025, impacting manufacturing expenses.
- The Manufacturing Index contracted in December 2025, indicating a slowdown in Germany's economic activity.
- Consumer confidence deteriorated to -17.5 in December 2025, dampening discretionary health spending.
- German industrial production inched up by 0.8% year-over-year in October 2025, despite overall contraction.
- Unemployment at 6.2% and CPI at 1.8% in December 2025 impacted consumer purchasing power.
Why did the price of Bupropion change in December 2025 in Europe?
- Producer Price Index declined by 2.5% year-over-year in December 2025, reducing manufacturing input costs.
- Bromine feedstock costs in Europe inched down in November 2025, lowering Bupropion production expenses.
- Contracting Manufacturing Index in December 2025 signaled weaker industrial activity and dampened demand.
For the Quarter Ending September 2025
Bupropio Prices in North America
- In United States, Bupropion Price Index rose in Q3 2025, driven by rising production costs.
- Bupropion production costs increased in Q3 2025, influenced by 2.6% PPI rise in August 2025.
- Bupropion demand supported by 5.42% retail sales increase and 4.3% unemployment in September 2025.
- Bupropion demand faced headwinds from 3.0% CPI increase and declining consumer confidence in September 2025.
- US manufacturing inventories tightened in Q3 2025; chemical inventories shrank due to destocking.
- US chemical manufacturing output contracted in Q3 2025; nondurable goods production slipped in September.
- Bupropion Price Forecast indicates upward pressure from sustained pharmaceutical intermediate demand and rising costs.
- Trade tensions and U.S. tariffs on imported chemicals impacted the market in Q3 2025, affecting supply.
- Strengthened US pharmaceutical market sentiment and drug approvals in Q3 2025 supported generic demand.
Why did the price of Bupropion change in September 2025 in North America?
- Bupropion input costs increased in Q3 2025, driven by 2.6% PPI rise in August.
- US manufacturing and chemical inventories tightened in Q3 2025, limiting Bupropion supply.
- Strong retail sales (up 5.42% in September 2025) supported Bupropion demand.
Bupropio Prices in APAC
- In China, the Bupropion Price Index remained stable in Q3 2025, influenced by mixed macroeconomic signals.
- Bupropion production costs declined in Q3 2025, as PPI fell by 2.3% in September 2025, reducing factory-gate prices.
- Bupropion demand outlook was tempered by pessimistic consumer confidence, recorded at 89.6 in September 2025.
- The Pharmaceutical API market expanded in 2025, providing underlying support for Bupropion demand.
- Industrial production rose by 6.5% in September 2025, bolstering supply chain stability for Bupropion manufacturing.
- Retail sales grew by 3.0% in September 2025, indicating stable consumer spending power for medications.
- Persistent overcapacity in China's chemical industry during Q3 2025 influenced Bupropion supply and inventory.
- Natural gas prices stabilized in Q3 2025, contributing to stable energy costs for Bupropion production.
- The Manufacturing Index contracted in September 2025, signaling a broader slowdown affecting Bupropion's supply chain.
Why did the price of Bupropion change in September 2025 in APAC?
- Falling PPI (-2.3% in September 2025) reduced production costs, influencing Bupropion pricing.
- Pessimistic consumer confidence (89.6 in September 2025) tempered demand, impacting Bupropion price stability.
- Persistent chemical overcapacity in Q3 2025 contributed to ample supply, pressuring Bupropion prices.
Bupropio Prices in Europe
- In Germany, the Bupropion Price Index remained stable quarter-over-quarter in Q3 2025, reflecting balanced market dynamics.
- Bupropion production costs faced upward pressure from a 2.4% CPI in September 2025, increasing operational expenses.
- Conversely, a -1.7% PPI in September 2025 indicated lower producer input costs, easing Bupropion manufacturing expenses.
- The Bupropion demand outlook was supported by a low 3.9% unemployment rate in September 2025, bolstering consumer affordability.
- However, consumer confidence declined significantly by -23.6 index points in September 2025, posing a bearish demand outlook.
- High energy and raw material costs continued to burden the German chemical industry throughout Q3 2025, affecting Bupropion production.
- The Manufacturing Index contracting in September 2025, alongside a -1.0% industrial production decline, signaled broader economic slowdown.
- Bupropion price forecast suggests continued stability, as resilient pharmaceutical output balances general industrial weakness in Q3 2025.
Why did the price of Bupropion change in September 2025 in Europe?
- A -1.7% PPI in September 2025 indicated lower producer input costs, easing Bupropion production.
- High energy costs and a 2.4% CPI in September 2025 increased Bupropion operational burdens.
- Strong consumer affordability from a 3.9% unemployment rate balanced weak consumer confidence.
For the Quarter Ending December 2022
North America
North American region, primarily the United States market, displayed descending pricing sentiments for Bupropion throughout the final Quarter of 2022. At the start of the fourth quarter, the prices remained on the stable side as the demand remained dormant, following the trend of the previous month.
Market players continue to keep a close eye on various factors that have impacted the market of almost all commodities, including Bupropion. Till November, the prices remained sturdy, with moderate demand balanced with overall supplies within the domestic market. Following December, the cost of Bupropion declined considerably and got settled at USD 71850/ MT CFR Los Angeles.
Asia Pacific
The prices of Bupropion in the Asia Pacific region, majorly in China, demonstrated a significant dip with ending of the last Quarter of 2022. Government data showed the official manufacturing purchasing managers index (PMI) fell to 48.0 in November, slipping well below last month's reading of 49.2 as steadily rising COVID-19 cases in the fourth quarter caused further disruptions and the prices of all the commodities, including Bupropion. Due to restrictions on the export of all commodities, including Bupropion, China's main issue was managing congested logistics on the key trade channels to North America and Europe during November, which additionally affected the price trends of Bupropion. With the end of the fourth quarter of 2022, the prices of Bupropion got assembled at USD 71000/MT FOB Shanghai, with declining demand and stockpiling of inventories among the market players.
Europe
During the fourth quarter of 2022, the prices of Bupropion showed mixed market sentiments in the European region. October month witnessed a continuous decrement in end-user demand for Bupropion. Following November, the prices inclined considerably and got stable in December with the settlement of USD 75570/MT CFR Hamburg in Germany. Furthermore, Bupropion's price trend in Germany was supported by a rapid decline in supply chain interruption and shipping costs. However, as growing energy prices began to level down at the end of 2022, inflation in Europe declined in December for the second consecutive month. Due to a decline in international orders, notably from exporting nations like China, demand decreased from the previous month. However, the inventories, with market players', remained larger, and their inquiries weaker during the Thanksgiving break.
